Arezoo Rajabian

Arezoo Rajabian

Auto-generated profile, based on publicly available information

Arezoo Rajabian

Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

29 April 2023 in Archives of Virology
Verified
Journal Article
Open access
PDF file
TNTahereh Nazary
Tahereh Nazary
AAAzin Aghamajidi
Azin Aghamajidi
MDMaryam Dorfaki
Maryam Dorfaki
FKFatemeh Keshavarz
Fatemeh Keshavarz
ZSZahra Shafaghat
Zahra Shafaghat
RJReza Jafari
Reza Jafari
B lymphocytes play a vital role in the human defense against viral infections by producing specific antibodies. They are also critical for the prevention of infectious diseases by vaccination, and their activation influences the efficacy of the vaccination. Since the beginning of coronavirus disease 2019 (COVID-19), which became the main concern of the world health system, many efforts have been made to treat and prevent the disease. However, for the development of successful therapeutics and vaccines, it is necessary to understand the interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, and the immune system. The innate immune system provides primary and nonspecific defense against the virus, but within several days after infection, a virus-specific immune response is provided first by antibody-producing B cells, which are converted after the resolution of disease to memory B cells, which provide long-term immunity. Although a failure in B cell activation or B cell dysfunction can cause a severe form of the disease and also lead to vaccination inefficiency, some individuals with B cell immunodeficiency have shown less production of the cytokine IL-6, resulting in a better disease outcome. In this review, we present the latest findings on the interaction between SARS-CoV-2 and B lymphocytes during COVID-19 infection.

28 March 2022 in Physiological Reports
Verified
Journal Article
Open access
PHParichehr Hayatdavoudi
Parichehr Hayatdavoudi
MHMahmoud Hosseini
Mahmoud Hosseini
VHVahid Hajali
Vahid Hajali
AHAzar Hosseini
Azar Hosseini
ARArezoo Rajabian
Arezoo Rajabian
Epilepsy affects about 1% of the population and approximately 30% of epileptic patients are resistant to current antiepileptic drugs. As a hallmark in epileptic tissue, many of the epileptic patients show changes in glia morphology and function. There are characteristic changes in different types of glia in different epilepsy models. Some of these changes such as astrogliosis are enough to provoke epileptic seizures. Astrogliosis is well known in mesial temporal lobe epilepsy (MTLE), the most common form of refractory epilepsy. A better understanding of astrocytes alterations could lead to novel and efficient pharmacological approaches for epilepsy. In this review, we present the alterations of astrocyte morphology and function and present some instances of targeting astrocytes in seizure and epilepsy.

25 November 2023 in Heliyon
Verified
Journal Article
Open access
NMNasrin Mehranfard
Nasrin Mehranfard
MGMaedeh Ghasemi
Maedeh Ghasemi
ARArezoo Rajabian
Arezoo Rajabian
LALegha Ansari
Legha Ansari
Increasing evidence suggests that elevated intracellular levels of reactive oxygen species (ROS) play a significant role in the pathogenesis of many diseases. Increased intracellular levels of ROS can lead to the oxidation of lipids, DNA, and proteins, contributing to cellular damage. Hence, the maintenance of redox hemostasis is essential. Naringenin (NAR) is a flavonoid included in the flavanones subcategory. Various pharmacological actions have been ascribable to this phytochemical composition, including antioxidant, anti-inflammatory, antibacterial, antiviral, antitumor, antiadipogenic, neuro-, and cardio-protective activities. This review focused on the underlying mechanism responsible for the antioxidative stress properties of NAR and its' nanoformulations. Several lines of in vitro and in vivo investigations suggest the effects of NAR and its nanoformulation on their target cells via modulating signaling pathways. These nanoformulations include nanoemulsion, nanocarriers, solid lipid nanoparticles (SLN), and nanomicelle. This review also highlights several beneficial health effects of NAR nanoformulations on human diseases including brain disorders, cancer, rheumatoid arthritis, and small intestine injuries. Employing nanoformulation can improve the pharmacokinetic properties of NAR and consequently efficiency by reducing its limitations, such as low bioavailability. The protective effects of NAR and its’ nanoformulations against oxidative stress may be linked to the modulation of Nrf2-heme oxygenase-1, NO/cGMP/potassium channel, COX-2, NF-κB, AMPK/SIRT3, PI3K/Akt/mTOR, BDNF, NOX, and LOX-1 pathways. Understanding the mechanism behind the protective effects of NAR can facilitate drug development for the treatment of oxidative stress-related disorders.

22 September 2022 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
SASabiheh Amirahmadi
Sabiheh Amirahmadi
FFFaezeh Dabouri Farimani
Faezeh Dabouri Farimani
MAMahsan Akbarian
Mahsan Akbarian
FMFarshad Mirzavi
Farshad Mirzavi
MGMohammad Hossein Eshaghi Ghalibaf
Mohammad Hossein Eshaghi Ghalibaf
MHMahmoud Hosseini
Mahmoud Hosseini

4 January 2022 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
SRSeyed Hamidreza Rastegar-Moghaddam
Seyed Hamidreza Rastegar-Moghaddam
MHMahmoud Hosseini
Mahmoud Hosseini
FAFatemeh Alipour
Fatemeh Alipour
ARArezoo Rajabian
Arezoo Rajabian
AEAlireza Ebrahimzadeh-bideskan
Alireza Ebrahimzadeh-bideskan